Expert interview with Jason Gotlib
EHA Learning Center, Jason R. Gotlib, 256798
Expert interview with James Ferrara
EHA Learning Center, James Ferrara, 256799
Expert interview with David Weinstock
EHA Learning Center, David Weinstock, 256800
Expert interview with Charles Craddock
EHA Learning Center, Charles Craddock, 256801
Expert interview with Sergio Giralt
EHA Learning Center, Sergio Giralt, 256802
Expert interview with Michael Pulsipher
EHA Learning Center, Michael Pulsipher, 256803
Expert interview with Loretta Nastoupil
EHA Learning Center, Loretta Nastoupil, 256804
Expert interview with Ann Mullally
EHA Learning Center, Ann Mullally, 256805
Expert interview with Alex Herrera
EHA Learning Center, Alex Herrera, 256806
Expert interview with Laura Micharlis
EHA Learning Center, Laura Micharlis, 256807
MOA and Manufacturing of CAR T-cell Therapy
EHA Learning Center, Delivered by Novartis, 234312
Alas1 Is Essential For Neutrophil Maturation In Zebrafish
EHA Learning Center, Junwei Lian, 234395
The SLC40A1 R178Q Mutation Is A Recurrent Cause Of Hemochromatosis And Is Associated With A Novel Pathogenic Mechanism
EHA Learning Center, Chandran Ka, 234396
Novel Lineage Depletion Preserves Autologous Blood Stem Cells For Gene Therapy Of Fanconi Anemia Complementation Group A
EHA Learning Center, Jennifer E. Adair, 234397
Prognostic Factors Of Erdheim–Chester Disease: A Nationwide Survey In Japan
EHA Learning Center, Takashi Toya, 234398
Reduced Tyrosine Kinase Inhibitor Dose Is Predicted To Be As Effective As Standard Dose In Chronic Myeloid Leukemia: A Simulation Study Based On Phase III Trial Data
EHA Learning Center, Artur C. Fassoni, 234399
Inhibition Of Protein Disulfide Isomerase Induces Differentiation Of Acute Myeloid Leukemia Cells
EHA Learning Center, Justyna Chlebowska-Tuz, 234400
MDM2- And FLT3-Inhibitors In The Treatment Of FLT3-ITD Acute Myeloid Leukemia, Specificity And Efficacy Of NVP-HDM201 And Midostaurin
EHA Learning Center, Katja Seipel, 234401
Adherence To The Western, Prudent, And Mediterranean Dietary Patterns And Chronic Lymphocytic Leukemia In The MCC-Spain Study
EHA Learning Center, Marta Solans, 234402
Inferior Survival In High-Grade B-Cell Lymphoma With MYC And BCL2 And/Or BCL6 Rearrangements Is Not Associated With MYC/IG Gene Rearrangements
EHA Learning Center, Ellen D. McPhail, 234403
PD-L1+ Tumor-Associated Macrophages And PD-1+ Tumor-Infiltrating Lymphocytes Predict Survival In Primary Testicular Lymphoma
EHA Learning Center, Marjukka Pollari, 234404
A Phase II/III Randomized, Multicenter Trial Of Prednisone/Sirolimus Versus Prednisone/ Sirolimus/Calcineurin Inhibitor For The Treatment Of Chronic Graft-Versus-Host Disease: BMT CTN 0801
EHA Learning Center, Paul A. Carpenter, 234405
N-Linked Glycosylation Modulates The Immunogenicity Of Recombinant Human Factor VIII In Hemophilia A Mice
EHA Learning Center, Jesse D. Lai, 234406
Treatment-Free Remission After Two-Year Consolidation Therapy With Nilotinib In Patients With Chronic Myeloid Leukemia: STAT2 Trial In Japan
EHA Learning Center, Naoto Takahashi, 234407
Radiation Exposure From Computerized Tomography And Risk Of Childhood Leukemia: Finnish Register-Based Case-Control Study Of Childhood Leukemia (FRECCLE)
EHA Learning Center, Atte Nikkilä, 234408
Genetics Of Acute Myeloid Leukemia In The Elderly: Mutation Spectrum And Clinical Impact In Intensively Treated Patients Aged 75 Years Or Older
EHA Learning Center, Victoria Prassek, 234409
Safety Of Obinutuzumab Alone Or Combined With Chemotherapy For Previously Untreated Or Relapsed/Refractory Chronic Lymphocytic Leukemia In The Phase IIIb GREEN Study
EHA Learning Center, Véronique Leblond, 234410
Clinical Cases Uncovered
EHA Learning Center, Shaun McCann, 179605
SCD - Interactive Content
EHA Learning Center, Delivered by Novartis, 234217
Sickle Cell Disease - VOC pathophysiology
EHA Learning Center, Delivered by Novartis, 234216
Managing CLL Patients In 2018: Updates From The Recent ASH Congress
EHA Learning Center, Delivered by Janssen, 233813
Interpreting ASH 2017 updates for your daily clinical practice a roundtable discussion on MM
EHA Learning Center, Delivered by Janssen, 233812
E-course on Thrombosis
EHA Learning Center, Course Faculty, 233290
Thrombosis The basics
EHA Learning Center, Roger Schutgens, 233293
Repopulating hematopoietic stem cells from steady-state blood before and after ex vivo culture are enriched in the CD34+CD133+CXCR4low fraction
EHA Learning Center, Véronique Lapostolle, 234239
Circulating iron levels influence the regulation of hepcidin following stimulated erythropoiesis
EHA Learning Center, Cornel S.G. Mirciov, 234240
Iron overload impairs normal hematopoietic stem and progenitor cells through reactive oxygen species and shortens survival in myelodysplastic syndrome mice
EHA Learning Center, Xin Jin, 234241
Bone marrow histomorphological criteria can accurately diagnose hemophagocytic lymphohistiocytosis
EHA Learning Center, Eric Gars, 234242
Combinatorial targeting of XPO1 and FLT3 exerts synergistic anti-leukemia effects through induction of differentiation and apoptosis in FLT3-mutated acute myeloid leukemias: from concept to clinical trial
EHA Learning Center, Weiguo Zhang, 234243
Addition of the mammalian target of rapamycin inhibitor, everolimus, to consolidation therapy in acute myeloid leukemia: experience from the UK NCRI AML17 trial
EHA Learning Center, Alan K Burnett, 234244
Therapy-related acute lymphoblastic leukemia has distinct clinical and cytogenetic features compared to de novo acute lymphoblastic leukemia, but outcomes are comparable in transplanted patients
EHA Learning Center, Ibrahim Aldoss, 234245
CDCA7 is a critical mediator of lymphomagenesis that selectively regulates anchorage-independent growth
EHA Learning Center, Raúl Jiménez-P, 234246
Pre-diagnosis plasma immune markers and risk of non-Hodgkin lymphoma in two prospective cohort studies
EHA Learning Center, Mara M. Epstein, 234247
Immunomodulatory drugs downregulate IKZF1 leading to expansion of hematopoietic progenitors with concomitant block of megakaryocytic maturation
EHA Learning Center, Ailing Liu, 234248
The eGVHD App has the potential to improve the accuracy of graft-versus-host disease assessment: a multicenter randomized controlled trial
EHA Learning Center, Helene M. Schoemans, 234249
Upper gastrointestinal acute graft-versus-host disease adds minimal prognostic value in isolation or with other graft-versus-host disease symptoms as currently diagnosed and treated
EHA Learning Center, Sarah Nikiforow, 234250
CD16+NK-92 and anti-CD123 monoclonal antibody prolongs survival in primary human acute myeloid leukemia xenografted mice
EHA Learning Center, Brent A. Williams, 234251
Cytoprotective and pro-angiogenic functions of thrombomodulin are preserved in the C loop of the fifth epidermal growth factor-like domain
EHA Learning Center, Xiangmin Wang, 234252
A subset of anti-HLA antibodies induces FcγRIIa-dependent platelet activation
EHA Learning Center, Maaike Rijkers, 234253
Transient inhibition of NF-κB signaling enhances ex vivo propagation of human hematopoietic stem cells
EHA Learning Center, Mehrnaz Safaee Talkhoncheh, 234224
Hematopoietic stem cell loss and hematopoietic failure in severe aplastic anemia is driven by macrophages and aberrant podoplanin expression
EHA Learning Center, Amanda McCabe, 234225
Transforming growth factor β1-mediated functional inhibition of mesenchymal stromal cells in myelodysplastic syndromes and acute myeloid leukemia
EHA Learning Center, Stefanie Geyh, 234226
Pharmacological inhibition of dihydroorotate dehydrogenase induces apoptosis and differentiation in acute myeloid leukemia cells
EHA Learning Center, Dang Wu, 234227
Clofarabine, high-dose cytarabine and liposomal daunorubicin in pediatric relapsed/refractory acute myeloid leukemia: a phase IB study
EHA Learning Center, Natasha K.A. van Eijkelenburg, 234228
Investigating chemoresistance to improve sensitivity of childhood T-cell acute lymphoblastic leukemia to parthenolide
EHA Learning Center, Benjamin C. Ede, 234229
Sustained efficacy and detailed clinical follow-up of first-line ibrutinib treatment in older patients with chronic lymphocytic leukemia: extended phase 3 results from RESONATE-2
EHA Learning Center, Paul M. Barr, 234230
Real-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States
EHA Learning Center, Anthony R. Mato, 234231
A phase I/II dose-escalation study investigating all-oral ixazomib-melphalan-prednisone induction followed by single-agent ixazomib maintenance in transplant-ineligible newly diagnosed multiple myeloma
EHA Learning Center, Jesús F. San-Miguel, 234232
Competing-risk outcomes after hematopoietic stem cell transplantation from the perspective of time-dependent effects
EHA Learning Center, Daniel Fuerst, 234233
Patient-reported outcomes and health status associated with chronic graft-versus-host disease
EHA Learning Center, Stephanie Lee, 234234
Transfusion of packed red blood cells at the end of shelf life is associated with increased risk of mortality – a pooled patient data analysis of 16 observational trials
EHA Learning Center, Monica S.Y. Ng, 234235
Frequency, risk factors, and impact on mortality of arterial thromboembolism in patients with cancer
EHA Learning Center, Ella Grilz, 234236
Impaired mitochondrial activity explains platelet dysfunction in thrombocytopenic cancer patients undergoing chemotherapy
EHA Learning Center, Constance C. F. M. J. Baaten, 234237
NLRP3 regulates platelet integrin αIIbβ3 outside-in signaling, hemostasis and arterial thrombosis
EHA Learning Center, Jianlin Qiao, 234238
Dexamethasone promotes durable factor VIII-specific tolerance in hemophilia A mice via thymic mechanisms
EHA Learning Center, Maria T Georgescu, 226762
The early expansion of anergic NKG2Apos/CD56dim/CD16neg natural killer represents a therapeutic target in haploidentical hematopoietic stem cell transplantation
EHA Learning Center, Alessandra Roberto, 226761
Meaningful changes in end-of-life care among patients with myeloma
EHA Learning Center, Oreofe O. Odejide, 226760
Therapeutic effects of the novel subtype-selective histone deacetylase inhibitor chidamide on myeloma-associated bone disease
EHA Learning Center, Jingsong He, 226759
Maternal embryonic leucine zipper kinase inhibitor OTSSP167 has preclinical activity in multiple myeloma bone disease
EHA Learning Center, Joséphine Muller, 226758
A phase II multicenter study of the anti-CD19 antibody drug conjugate coltuximab ravtansine (SAR3419) in patients with relapsed or refractory diffuse large B-cell lymphoma previously treated with rituximab-based immunotherapy
EHA Learning Center, Marek Trneny, 226757
Rituximab plus bendamustine as front-line treatment in frail elderly (>70 years) patients with diffuse large B-cell non-Hodgkin lymphoma: a phase II multicenter study of the Fondazione Italiana Linfomi
EHA Learning Center, Sergio Storti, 226756
End-of-treatment and serial PET imaging in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R: a paradigm shift in clinical decision making
EHA Learning Center, Christopher Melani, 226755
Novel GPR34 and CCR6 mutation and distinct genetic profiles in MALT lymphomas of different sites
EHA Learning Center, Sarah Moody, 226754
Outcomes of hematopoietic stem cell transplantation from unmanipulated haploidentical versus matched sibling donor in patients with acute myeloid leukemia in first complete remission with intermediate or high-risk cytogenetics: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
EHA Learning Center, Dalila Salvatore, 226753
Phase I trial of plerixafor combined with decitabine in newly diagnosed older patients with acute myeloid leukemia
EHA Learning Center, Gail Roboz, 226752
Safety and efficacy of second-line bosutinib for chronic phase chronic myeloid leukemia over a five-year period: final results of a phase I/II study
EHA Learning Center, Carlo Gambacorti-Passerini, 226751
The interleukin-3 receptor CD123 targeted SL-401 mediates potent cytotoxic activity against CD34+CD123+ cells from acute myeloid leukemia/myelodysplastic syndrome patients and healthy donors
EHA Learning Center, Rajeswaran Mani, 226750
Natural history of GATA2 deficiency in a survey of 79 French and Belgian patients
EHA Learning Center, Jean Donadieu, 226749
CARD10, a CEBPE target involved in granulocytic differentiation
EHA Learning Center, Pavithra Shyamsunder, 226748
A Paradigm Shift: Emerging Therapies in Flt3-Positive AML
EHA Learning Center, Delivered by Novartis, 224083
Setd2 regulates quiescence and differentiation of adult hematopoietic stem cells by restricting RNA polymerase II elongation
EHA Learning Center, Yle Zhou, 224103
Endothelin type A receptors mediate pain in a mouse model of sickle cell disease
EHA Learning Center, Brianna Marie Lutz, 224104
Proteomic analysis of plasma from children with sickle cell anemia and silent cerebral infarction
EHA Learning Center, Sanjay Tewari, 224105
Late effects after hematopoietic stem cell transplantation for β-thalassemia major: the French national experience
EHA Learning Center, Ilhem Rahal, 224106
Circulating exosomal microRNAs in acquired aplastic anemia and myelodysplastic syndromes
EHA Learning Center, Valentina Giudice, 224107
JAK2V617F-bearing vascular niche enhances malignant hematopoietic regeneration following radiation injury
EHA Learning Center, Chi Hua Sarah Lin, 224108
The chromatin-remodeling factor CHD4 is required for maintenance of childhood acute myeloid leukemia
EHA Learning Center, Yaser Heshmati, 224109
Gene expression profiling reveals a close relationship between follicular lymphoma grade 3A and 3B, but distinct profiles of follicular lymphoma grade 1 and 2
EHA Learning Center, Heike Horn, 224110
The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective, International T-Cell Project
EHA Learning Center, Monica Bellei, 224111
Low-count monoclonal B-cell lymphocytosis persists after seven years of follow up and is associated with a poorer outcome
EHA Learning Center, Ignacio Criado, 224112
Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study
EHA Learning Center, Antonio Cuneo, 224113
Repurposing tofacitinib as an anti-myeloma therapeutic to reverse growth-promoting effects of the bone marrow microenvironment
EHA Learning Center, Christine Lam, 224114
Plasma cell proliferative index predicts outcome in immunoglobulin light chain amyloidosis treated with stem cell transplantation
EHA Learning Center, M. Hasib Sidiqi, 224115
Platelet Munc13-4 regulates hemostasis, thrombosis and airway inflammation
EHA Learning Center, Eduardo I. Cardenas, 224116
C-reactive protein and risk of venous thromboembolism: results from a population-based case-crossover study
EHA Learning Center, Gro Grimnes, 224117
A 43-year-old woman
EHA Learning Center, Maria Domenica Cappellini, 221465
Macrocytic anaemia with thrombocytosis
EHA Learning Center, Jaroslav Cermak, 221464
Expert interview with Wilma Barcellini
EHA Learning Center, Wilma Barcellini, 226242
Expert interview with Eleni Gavriilaki
EHA Learning Center, Eleni Gavriilaki, 226241
Expert interview with Jacqueline Boultwood
EHA Learning Center, Jacqueline Boultwood, 226240

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.

Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.

Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.

Save Settings